NCT06683846
- Conditions
- Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Non-Clear Cell Renal Cell Carcinoma
Explore clinical trials studying Non-Clear Cell Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Non-Clear Cell Renal Cell Carcinoma trial results
Not Yet Recruiting
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
NCT07689240
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
Not specified
Active, Not Recruiting
Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma
NCT07488533
- Conditions
- Non-Clear Cell Renal Cell Carcinoma
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Active, Not Recruiting
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
NCT05678673
- Conditions
- Non-Clear Cell Renal Cell Carcinoma
- Locations
-
- Exelixis Clinical Site #1 Duarte, California, United States
- Exelixis Clinical Site #164 Newport Beach, California, United States
- Exelixis Clinical Site #162 San Francisco, California, United States
- Exelixis Clinical Site #163 Aurora, Colorado, United States